ClinicalTrials.gg
RecruitingNCT07764185RechargeUpdated Aug 21, 2026

Caring Recharge Project for Caregivers of Individuals With Alzheimer's Disease

A Phase 2 interventional study of Recharge Behavioral Therapy and Traditional Educational/Resources Program in Caregiver Stress, sponsored by Photozig, Inc.. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-21.

Sponsored by Photozig, Inc. · Phase 2, Interventional, and Supportive care

From the registry’s dates

  • Started Aug 2026; still recruiting 2 months later.
Phase
Phase 2
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 227 studies in Caregiver Burden with a site in United States — 59 open to participants now, 72 under way, 1 of them phase 3. Caregiver Burden · United States.

Planned enrollment
49th of 207
150 · median 60
Started
2026
with 18 others
Phase 2
8 of 227
2 open now
Primary completion
2027-05
later than 33 of 71 live
Registered
220th of 227
by date

Among the 227 studies in Caregiver Burden with a site in United States, this one is the 49th largest by planned enrollment of the 207 interventional ones that give a count, is one of 19 that started in 2026, is one of 8 in phase 2, reaches primary completion later than 33 of the 71 other live ones, and was the 220th registered.

Caregiver Burden

500 studies on the registry are indexed under Caregiver Burden; 164 are open to participants now.

Browse Caregiver Burden studies →

Open to participants now

59 of the 227 studies in Caregiver Burden with a site in United States are open now. Recruiting first, the newest first:

53 more — sign in →

All 59 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 88 Caregiver Burden studies recruiting now, 67 (76%) set no upper age limit and 7 (8%) stop at 75 or younger; 8 take children under 18; 38 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 227 studies in Caregiver Burden with a site in United States, or all of them as a file.
02

Study summary

This project will evaluate the effectiveness of the Recharge Behavioral Therapy (RBT) intervention to alleviate stress and depressive symptoms of caregivers of Individuals with Alzheimer's Disease and Related Dementia.

03

Conditions studied

  • Caregiver Stress

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Care for an individual with Alzheimer s Disease or other dementia.
  • Have a Smartphone or tablet with Internet access.
  • Minimum age of 18 years old.
  • Spend at least 8 hours/week caring for a person with dementia.

Exclusion criteria

Exclusion Criteria:

  • Severe psychological or physical illness.
  • Inability to read and follow instructions.
  • Unwillingness to participate in all aspects of the study.
05

Study design

Phase
Phase 2
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    Caring Recharge mobile app

    Participants will receive the Caring Recharge mobile app containing the Recharge Behavioral Therapy program.

    Behavioral: Recharge Behavioral Therapy

  • Active comparator
    Traditional educational program

    Participants will receive a traditional educational/resources program, containing a downloadable workbook and online resources.

    Behavioral: Traditional Educational/Resources Program

Interventions

  • BehavioralRecharge Behavioral Therapy

    Participants will receive the Caring Recharge mobile app containing the Recharge Behavioral Therapy.

  • BehavioralTraditional Educational/Resources Program

    Participants will receive a traditional educational/resources program, containing a downloadable workbook and online resources.

06

What researchers measure

Primary outcomes

  1. Center for Epidemiological Studies Depression Scale

    The Center for Epidemiological Studies Depression scale (CES-D) is a 20-item measure that asks about the frequency of depressive symptoms (affective, psychological, and somatic) within the past week. The scale refers to the caregiver. Minimum score (best value)=0. Maximum score (worst value)=60. Higher values represent a worse outcome.

    Time frame: 3 months

  2. Perceived Stress Scale

    The "Perceived Stress Scale" measures the overall level of stress. This instrument contains 10 items accessing overall appraisals of stress in the past month. The scale refers to the caregiver. Minimum score (best value)=0. Maximum score (worst value)=40. Higher values represent a worse outcome.

    Time frame: 3 months

07

Study locations

1 of 1 sites recruiting
  • Photozig, Inc.
    Campbell, California 95008, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Aug 2026 (actual). Primary completion is estimated for May 2027, 9 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 9, 2026
First posted
Aug 13, 2026
StartActual
Aug 14, 2026
Primary completionEst.
May 31, 2027
CompletionEst.
May 31, 2027
Last update
Aug 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07764185
Lead sponsor
Photozig, Inc.
Responsible party
Sponsor
First posted
Aug 13, 2026
Start date
Aug 14, 2026
Primary completion
May 31, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Aug 21, 2026

Study contacts

Bruno Kajiyama
Contact
caring@photozig.com
855-955-CARE

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion